Chardan Capital Markets is an independent investment bank headquartered in New York, with additional offices in Greenwich, Connecticut. Founded in 2003, the bank specializes in providing a comprehensive range of investment banking services, focusing on sectors such as healthcare, technology, and emerging growth companies.
Chardan is recognized for its leading position in the SPAC (Special Purpose Acquisition Company) market, having underwritten over 120 SPACs. The firm plays a pivotal role in advising on mergers and acquisitions, equity and debt financing, and initial public offerings, particularly for biotech and technology enterprises.
The bank has a strong emphasis on research and corporate access, aiming to facilitate connections between innovative companies and institutional investors. Chardan's deep expertise in the healthcare sector has enabled it to successfully raise more than $10 billion since its inception, supporting companies in bringing disruptive technologies and therapies to market. As of 2023, Chardan continues to expand its footprint in both domestic and international markets, adapting to the evolving landscape of investment banking.
By using this website, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
